Adjuvant Embolization With N-Butyl Cyanoacrylate in the Treatment of Cerebral Arteriovenous Malformations Outcomes, Complications, and Predictors of Neurologic Deficits

被引:75
|
作者
Starke, Robert M.
Komotar, Ricardo J.
Otten, Marc L.
Hahn, David K. [2 ]
Fischer, Laura E.
Hwang, Brian Y.
Garrett, Matthew C.
Sciacca, Robert R.
Sisti, Michael B.
Solomon, Robert A.
Lavine, Sean D. [3 ]
Connolly, E. Sander
Meyers, Philip M. [1 ,3 ]
机构
[1] Columbia Univ, Dept Neurosurg, Neurol Inst, New York, NY 10032 USA
[2] Northwestern Univ, Dept Neurosurg, Chicago, IL 60611 USA
[3] Columbia Univ, Dept Intervent Neuroradiol, New York, NY 10032 USA
关键词
arteriovenous malformation; complication; embolization; outcome; surgery; PREOPERATIVE EMBOLIZATION; ENDOVASCULAR TREATMENT; GRADING SYSTEM; STEREOTAXIC RADIOSURGERY; SURGICAL-MANAGEMENT; BASAL GANGLIA; BRAIN; EXPERIENCE; DETERMINANTS; SURGERY;
D O I
10.1161/STROKEAHA.108.539775
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose-The purpose of this study was to assess the frequency, severity, and predictors of neurological deficits after adjuvant embolization for cerebral arteriovenous malformations. Methods-From 1997 to 2006, 202 of 275 patients with arteriovenous malformation received embolization before microsurgery (n = 176) or radiosurgery (n = 26). Patients were examined before and after endovascular embolization and at clinical follow-up (mean, 43.4 +/- 34.6 months). Outcome was classified according to the modified Rankin Scale. New neurological deficits after embolization were defined as minimal (no change in overall modified Rankin Scale), moderate (modified Rankin Scale <= 2), or significant (modified Rankin Scale > 2). Results-Two hundred two patients were treated in 377 embolization procedures. There were a total of 29 new clinical deficits after embolization (8% of procedures; 14% of patients), of which 19 were moderate or significant. Postembolization deficits resolved in a significant number of patients over time (P < 0.0001). Five patients had persistent neurological deficits due to embolization (1.3% of procedures; 2.5% of patients). In multivariate analysis, the following variables significantly predicted new neurological deficit after embolization: complex arteriovenous malformation with treatment plan specifying more than one embolization procedure (OR, 2.7; 95% CI, 1.4 to 8.6), diameter < 3 cm (OR, 3.2; 95% CI, 1.2 to 9.1), diameter > 6 cm (OR, 6.2; 95% CI, 1.0 to 57.0), deep venous drainage (OR, 2.7; 95% CI, 1.1 to 6.9), or eloquent location (OR, 2.4; 95% CI, 1.0 to 5.7). These variables were weighted and used to compute an arteriovenous malformation Embolization Prognostic Risk Score for each patient. A score of 0 predicted no new deficits, a score of 1 predicted a new deficit rate of 6%, a score of 2 predicted a new deficit rate of 15%, a score of 3 predicted a new deficit rate of 21%, and a score of 4 predicted a new deficit rate of 50% (P < 0.0001). Conclusions-Small and large size, eloquent location, deep venous drainage, and complex vascular anatomy requiring multiple embolization procedures are risk factors for the development of immediate postembolization neurological deficits. Nevertheless, a significant number of patients with treatment-related neurological deficits improve over time. The low incidence of permanent neurological deficits underscores the usefulness of this technique in carefully selected patients. (Stroke. 2009; 40: 2783-2790.)
引用
收藏
页码:2783 / 2790
页数:8
相关论文
共 50 条
  • [11] Morbidity and mortality associated with sequential flow reduction embolization technique of cerebral arteriovenous malformations using n-butyl cyanoacrylate
    See, Alfred P.
    Mohammaden, Mahmoud H.
    Rizko, Mark
    Stapleton, Christopher J.
    Amin-Hanjani, Sepideh
    Charbel, Fady T.
    Aletich, Victor
    Alaraj, Ali
    JOURNAL OF NEUROINTERVENTIONAL SURGERY, 2021, 13 (03) : 237 - 241
  • [12] Polidocanol Sclerotherapy Combined with Transarterial Embolization Using n-Butyl Cyanoacrylate for Extracranial Arteriovenous Malformations
    Akira Kitagawa
    Takahiro Yamamoto
    Nozomu Matsunaga
    Mayako Yamaji
    Shuji Ikeda
    Yuichiro Izumi
    Makiyo Hagihara
    Toyohiro Ota
    Tsuneo Ishiguchi
    CardioVascular and Interventional Radiology, 2018, 41 : 856 - 866
  • [13] Polidocanol Sclerotherapy Combined with Transarterial Embolization Using n-Butyl Cyanoacrylate for Extracranial Arteriovenous Malformations
    Kitagawa, Akira
    Yamamoto, Takahiro
    Matsunaga, Nozomu
    Yamaji, Mayako
    Ikeda, Shuji
    Izumi, Yuichiro
    Hagihara, Makiyo
    Ota, Toyohiro
    Ishiguchi, Tsuneo
    CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2018, 41 (06) : 856 - 866
  • [14] Brain arteriovenous malformation nidus embolization with N-butyl cyanoacrylate
    Aletich, VA
    Debrun, GM
    Koenigsberg, RA
    Ausman, JI
    Charbel, FT
    Dujovny, M
    RADIOLOGY, 1996, 201 : 586 - 586
  • [15] Preoperative Embolization of Venous Malformations Using n-Butyl Cyanoacrylate
    Uller, Wibke
    El-sobky, Sherif
    Alomari, Ahmad I.
    Fishman, Steven J.
    Spencer, Samantha A.
    Taghinia, Amir H.
    Chaudry, Gulraiz
    VASCULAR AND ENDOVASCULAR SURGERY, 2018, 52 (04) : 269 - 274
  • [16] Embolization as an adjuvant in the treatment of cerebral arteriovenous malformations: Predicting complications and outcome
    Starke, Robert M.
    Komotar, Ricarc O. J.
    Haque, Raqeeb M.
    Otten, L.
    Hwang, Brian Y.
    Fischer, Laura
    Garrett, Matthew C.
    Merkow, Maxwell B.
    Sisti, Mihael B.
    Solomon, Robert A.
    Lavine, Sean D.
    Connolly, E. Sander, Jr.
    Meyers, Philip M.
    NEUROSURGERY, 2008, 62 (06) : 1404 - 1404
  • [17] Neurological outcomes and cure rates of embolization of brain arteriovenous malformations with n-butyl cyanoacrylate or Onyx: a meta-analysis
    Elsenousi, Abdussalam
    Aletich, Victor A.
    Alaraj, Ali
    JOURNAL OF NEUROINTERVENTIONAL SURGERY, 2016, 8 (03) : 265 - 272
  • [18] Ethanolamine oleate sclerotherapy combined with transarterial embolization using n-butyl cyanoacrylate for extracranial arteriovenous malformations
    Akira Kitagawa
    Yuichiro Izumi
    Makiyo Hagihara
    Seiji Kamei
    Shuji Ikeda
    Eisuke Katsuda
    Junko Kimura
    Toyohiro Ota
    Tsuneo Ishiguchi
    CardioVascular and Interventional Radiology, 2014, 37 : 371 - 380
  • [19] Transcatheter Arterial Embolization with n-Butyl Cyanoacrylate for the Treatment of Acquired Uterine Vascular Malformations
    Andrew C. Picel
    Sonya J. Koo
    Anne C. Roberts
    CardioVascular and Interventional Radiology, 2016, 39 : 1170 - 1176
  • [20] Transcatheter Arterial Embolization with n-Butyl Cyanoacrylate for the Treatment of Acquired Uterine Vascular Malformations
    Picel, Andrew C.
    Koo, Sonya J.
    Roberts, Anne C.
    CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2016, 39 (08) : 1170 - 1176